ARTHROPLASTY
THA: Heparin does not stop pelvic thrombi but may prevent ipsilateral femoral thrombi
J Arthroplasty. 2005 Jan;20(1):42-50165 patients undergoing unilateral primary THA, who had comorbidity that predisposed them for deep vein thrombosis (DVT), were randomized to receive a single intraoperative injection of heparin or saline. Over a minimum of 3 months, the 2 groups did not differ in the occurrence of pelvic thrombi. There was also no difference between the two groups in the mean size of thrombi, intraoperative blood loss, and post-operative swelling. However, none of the heparin group patients developed an ipsilateral femoral thrombus.The study, therefore, concluded that heparin may prevent ipsilateral femoral thrombi, but not pelvic thrombi.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
